2510 Meridian Parkway
About Health Decisions
Health Decisions is a full-service CRO specializing in clinical studies of therapeutics for women’s health indications and studies of diagnostics for all therapeutic areas. We have conducted full-service trials resulting in successful NDAs, PMAs and 510(k)s, and pride ourselves on the flexibility to adapt our service offerings to the needs and preferences of each sponsor and project.
Health Decisions has focused on women’s health since its inception more than 29 years ago, conducting more than 140 trials in women’s health indications such as contraception and postmenopausal vasomotor symptoms. We summarize our commitment to women’s health in one sentence: If it matters to women’s health, it matters to Health Decisions. Our experience enables us to address the challenges of developing women’s health products in areas including general gynecology indications, contraception, sexual health, infertility, obstetrics, menopause and osteoporosis and other indications that affect women disproportionately, including autoimmune disorders and male-factor infertility.
Health Decisions is a full-service CRO offering therapeutic and operational excellence for clinical development in all areas of women’s health. Our team has expertise in addressing the challenges of developing products that offer solutions to women’s health needs, including all health conditions that affect women disproportionately. We summarize our commitment to women's health in one sentence: If it matters to women's health, it matters to Health Decisions.
15 articles with Health Decisions
Health Decisions and OncoBay Clinical Partner to Provide Specialized Clinical Development Services in Women's Oncology
Health Decisions, Inc. and OncoBay Clinical, Inc. announced a partnership to deliver specialized clinical development services for pharmaceutical and biotechnology companies developing therapeutics, medical devices, and diagnostics in oncology.
Health Decisions, Inc., a full-service contract research organization (CRO) specializing in women's health clinical research and diagnostic development, today announced the appointment of Mary Gunn, PhD, MBA, LLM, as Chief Operating Officer (COO).
Daré Bioscience and Health Decisions Form Strategic Partnership to Accelerate the Development of Daré’s Novel Pipeline of Women’s Health Programs
Partnership Agreement Intended to Facilitate Advancement of Daré’s Programs in a Capital Efficient Manner; Includes Economic Structures and Dedicated Staff With Clinical Expertise in Women’s Health Products
Health Decisions Receives 4th Consecutive Appointment as Statistical and Clinical Coordinating Center for the Contraceptive Clinical Trials Network of the NICHD
Health Decisions, Inc., a full-service contract research organization specializing in women's health clinical research and diagnostic development, announced that it has been retained as the Statistical and Clinical Coordinating Center (SCCC) for the Contraceptive Clinical Trials Network (CCTN) of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), a unit of the National Institutes of Health (NIH).
The first trial to test the safety and efficacy of a reversible male contraceptive gel is underway. If approved, this could be the first male hormonal birth control on the market.
Health Decisions Completes Enrollment of Evofem's 3,400-subject Global Trial of Amphora® Non-hormonal Contraceptive Gel
Health Decisions Builds a Network of International CROs Trained in High-Efficiency Adaptive Research
Drug Tester Health Decisions Resists Trend; Company Plans to Add More Jobs Exceeding 200 by Year End
Health Decisions Appoints Rich Podurgal as Chief Human Resources Officer to Support Company’s Projected Growth